首页 > 最新文献

Cancer Research, Statistics, and Treatment最新文献

英文 中文
Breast-conserving surgery without irradiation in early breast cancer 早期乳腺癌保乳手术无放疗
Q1 Medicine Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_132_23
S. Mallick, Praful Pandey, A. Gogia
{"title":"Breast-conserving surgery without irradiation in early breast cancer","authors":"S. Mallick, Praful Pandey, A. Gogia","doi":"10.4103/crst.crst_132_23","DOIUrl":"https://doi.org/10.4103/crst.crst_132_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"26 10 1","pages":"361 - 362"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80702771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neoadjuvant pembrolizumab in advanced melanoma 新辅助派姆单抗治疗晚期黑色素瘤
Q1 Medicine Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_130_23
Praful Pandey, A. Gogia
{"title":"Neoadjuvant pembrolizumab in advanced melanoma","authors":"Praful Pandey, A. Gogia","doi":"10.4103/crst.crst_130_23","DOIUrl":"https://doi.org/10.4103/crst.crst_130_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"23 1","pages":"360 - 360"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87081588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fabrication of an interim obturator prosthesis for a patient with hypersensitive gag reflex 超敏感呕吐反射患者的临时闭孔假体的制作
Q1 Medicine Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_43_23
L. Gupta, S. Gurav, Avinash Kumar
{"title":"Fabrication of an interim obturator prosthesis for a patient with hypersensitive gag reflex","authors":"L. Gupta, S. Gurav, Avinash Kumar","doi":"10.4103/crst.crst_43_23","DOIUrl":"https://doi.org/10.4103/crst.crst_43_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"31 1","pages":"321 - 324"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87446520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ALK-driven NSCLC: A narrative review - Part I alk驱动的非小细胞肺癌:述评-第一部分
Q1 Medicine Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_75_23
S. Nathany, M. Sharma, U. Batra
Anaplastic lymphoma kinase (ALK)-rearranged non-small-cell lung cancer (NSCLC) is a molecularly distinct subgroup of oncogene-addicted NSCLC, accounting for 3-5% of cases. These are mainly genomic rearrangements resulting in a fusion oncoprotein, thus causing persistent constitutive signaling. Recent developments and approvals of various generations of ALK inhibitors have revamped the therapeutic and prognostic landscape of this disease entity. For the preparation of this review, we searched various databases such as PubMed, Embase, and Scopus, using the keywords “ALK,” “ALK crizotinib,” “Oncogene NSCLC,” and “Alectinib,” and we finally included 46 articles. In this review, we describe the molecular biology and pathologic and clinical characteristics of ALK-rearranged NSCLC. The detection methods, therapeutic strategies, and trials will be discussed in the next part of this biomarker review series.
间变性淋巴瘤激酶(ALK)重排非小细胞肺癌(NSCLC)是一种分子上独特的癌基因依赖性非小细胞肺癌亚群,占病例的3-5%。这些主要是导致融合癌蛋白的基因组重排,从而导致持续的构成信号。最近几代ALK抑制剂的开发和批准已经改变了这种疾病的治疗和预后前景。为了准备本综述,我们检索了PubMed、Embase和Scopus等多个数据库,检索关键词为“ALK”、“ALK crizotinib”、“Oncogene NSCLC”和“Alectinib”,最终纳入了46篇文章。本文就alk重排非小细胞肺癌的分子生物学、病理及临床特点作一综述。检测方法、治疗策略和试验将在本生物标志物综述系列的下一部分进行讨论。
{"title":"ALK-driven NSCLC: A narrative review - Part I","authors":"S. Nathany, M. Sharma, U. Batra","doi":"10.4103/crst.crst_75_23","DOIUrl":"https://doi.org/10.4103/crst.crst_75_23","url":null,"abstract":"Anaplastic lymphoma kinase (ALK)-rearranged non-small-cell lung cancer (NSCLC) is a molecularly distinct subgroup of oncogene-addicted NSCLC, accounting for 3-5% of cases. These are mainly genomic rearrangements resulting in a fusion oncoprotein, thus causing persistent constitutive signaling. Recent developments and approvals of various generations of ALK inhibitors have revamped the therapeutic and prognostic landscape of this disease entity. For the preparation of this review, we searched various databases such as PubMed, Embase, and Scopus, using the keywords “ALK,” “ALK crizotinib,” “Oncogene NSCLC,” and “Alectinib,” and we finally included 46 articles. In this review, we describe the molecular biology and pathologic and clinical characteristics of ALK-rearranged NSCLC. The detection methods, therapeutic strategies, and trials will be discussed in the next part of this biomarker review series.","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"78 1","pages":"272 - 278"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83318934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Erdafitinib for tumors with FGFR3 mutation: A promising targeted therapy 厄达非替尼治疗FGFR3突变肿瘤:一种有前景的靶向治疗
Q1 Medicine Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_176_23
Jaspreet Kaur, Ajay Singh, M. Shah, P. Chandrani, A. Chougule, O. Shetty, T. Pai, S. Menon, S. Yadav, A. Kapoor, B. Mishra, A. Dutt, V. Noronha, K. Prabhash
{"title":"Erdafitinib for tumors with FGFR3 mutation: A promising targeted therapy","authors":"Jaspreet Kaur, Ajay Singh, M. Shah, P. Chandrani, A. Chougule, O. Shetty, T. Pai, S. Menon, S. Yadav, A. Kapoor, B. Mishra, A. Dutt, V. Noronha, K. Prabhash","doi":"10.4103/crst.crst_176_23","DOIUrl":"https://doi.org/10.4103/crst.crst_176_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"95 1","pages":"288 - 295"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79549632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Advanced imaging techniques in deep inferior epigastric perforator (DIEP) flap breast reconstruction: The role of CT angiography 先进成像技术在腹下穿支皮瓣乳房重建中的作用
Q1 Medicine Pub Date : 2023-01-01 DOI: 10.4103/crst.crst_59_23
Shani George
{"title":"Advanced imaging techniques in deep inferior epigastric perforator (DIEP) flap breast reconstruction: The role of CT angiography","authors":"Shani George","doi":"10.4103/crst.crst_59_23","DOIUrl":"https://doi.org/10.4103/crst.crst_59_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"175 1","pages":"152 - 153"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72521746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
VIJAYA-The one who fights to win vijaya——为胜利而战的人
Q1 Medicine Pub Date : 2023-01-01 DOI: 10.4103/crst.crst_5_23
Vandana N. Mahajan
{"title":"VIJAYA-The one who fights to win","authors":"Vandana N. Mahajan","doi":"10.4103/crst.crst_5_23","DOIUrl":"https://doi.org/10.4103/crst.crst_5_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"2 1","pages":"65 - 67"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78359142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic role of NRAS-related pharmacogenetics in metastatic papillary thyroid carcinoma nras相关药物遗传学在转移性甲状腺乳头状癌中的预后作用
Q1 Medicine Pub Date : 2023-01-01 DOI: 10.4103/crst.crst_56_23
P. Bhargav, S. Mayilvaganan
{"title":"Prognostic role of NRAS-related pharmacogenetics in metastatic papillary thyroid carcinoma","authors":"P. Bhargav, S. Mayilvaganan","doi":"10.4103/crst.crst_56_23","DOIUrl":"https://doi.org/10.4103/crst.crst_56_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"159 1","pages":"170 - 171"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88677679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Rethinking euthanasia in the Indian context: Another perspective 在印度背景下重新思考安乐死:另一个视角
Q1 Medicine Pub Date : 2023-01-01 DOI: 10.4103/crst.crst_42_23
R. Shekhawat, Daideepya C Bhargava, Meenakshi Kumar
{"title":"Rethinking euthanasia in the Indian context: Another perspective","authors":"R. Shekhawat, Daideepya C Bhargava, Meenakshi Kumar","doi":"10.4103/crst.crst_42_23","DOIUrl":"https://doi.org/10.4103/crst.crst_42_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"6 1","pages":"133 - 134"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85347084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demographic insights into head-and-neck cancers 头颈癌的人口统计学研究
Q1 Medicine Pub Date : 2023-01-01 DOI: 10.4103/crst.crst_262_23
Kunal N. Jobanputra
Head-and-neck cancers are the most common malignancies in India.[1,2] These cancers exert a significant health burden in India, resulting in myriad social, economic, and psychological implications. The study conducted by Michaelraj et al.[3] meticulously delves into these cancers’ demographic and epidemiological characteristics in western Tamil Nadu. The local perspective from regional data sheds light on the concentrated distribution of these cancers and underscores the influential role of local variation in risk factors. Such insights hold the potential to inform targeted interventions encompassing education, prevention, and early detection strategies for these cancers.[4] The oral cavity predominantly serves as the primary site for head-and-neck cancers among Indian patients.[5] The study by Michaelraj et al.[3] identified the tongue as the most common subsite within this cohort of patients—a trend in line with other research studies conducted in south India. However, buccal mucosa traditionally ranks as India’s most common subsite for oral cavity cancers. It is worth noting that incorporating questions regarding the prevalence and practices of tobacco chewing within the questionnaire could have unveiled valuable insights. Furthermore, an exploration into the gender-based variations in the distribution of head-and-neck cancer sites could have enriched the study. Divergent risk factors across genders might significantly contribute to this disparity.[6] Among the critical determinants of survival in these aggressive cancers, the disease stage plays a major role. Data on the disease stage at presentation could have helped to devise appropriate strategies for earlier detection.[7] Although the study encompasses a cohort of 150 patients from a single tertiary-care institute in western Tamil Nadu, more comprehensive insights could have been gained by including a larger sample size from diverse centers across Tamil Nadu. Furthermore, tracking changes in cancer trends over the past decade could have yielded valuable temporal insights. In light of these considerations, the article by Michaelraj et al.[3] strongly underscores the paramount importance of tobacco, alcohol, and smoking as the foremost risk factors for these cancers.[8] Emphasis on comprehensive community-based tobacco cessation programs[9,10] emerges as a clear imperative. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
头颈癌是印度最常见的恶性肿瘤。[1,2]这些癌症在印度造成了巨大的健康负担,造成了无数的社会、经济和心理影响。Michaelraj等人进行的研究[3]细致地研究了泰米尔纳德邦西部这些癌症的人口统计学和流行病学特征。来自区域数据的地方视角揭示了这些癌症的集中分布,并强调了地方差异在危险因素中的影响作用。这些见解有可能为有针对性的干预提供信息,包括对这些癌症的教育、预防和早期发现策略。[4]在印度患者中,口腔是头颈癌的主要发病部位。[5]Michaelraj等人[3]的研究发现,在这组患者中,舌头是最常见的亚位点——这一趋势与在印度南部进行的其他研究一致。然而,口腔黏膜传统上被列为印度最常见的口腔癌亚区。值得注意的是,在调查问卷中纳入有关咀嚼烟草的流行程度和做法的问题可能会揭示有价值的见解。此外,对头颈癌分布中基于性别的差异的探索可能会丰富这项研究。不同性别的不同风险因素可能在很大程度上导致了这种差异。[6]在这些侵袭性癌症存活的关键决定因素中,疾病阶段起着重要作用。发病时的疾病阶段数据可以帮助制定适当的早期检测策略。[7]虽然这项研究只包括了泰米尔纳德邦西部一家三级医疗机构的150名患者,但如果能从泰米尔纳德邦不同中心获得更大的样本,就能获得更全面的见解。此外,追踪过去十年癌症趋势的变化可能会产生有价值的时间见解。考虑到这些因素,Michaelraj等人的文章[3]强烈强调了烟草、酒精和吸烟作为这些癌症的首要风险因素的重要性。[8]强调以社区为基础的综合性戒烟规划[9,10]已成为明确的当务之急。财政支持及赞助无。利益冲突没有利益冲突。
{"title":"Demographic insights into head-and-neck cancers","authors":"Kunal N. Jobanputra","doi":"10.4103/crst.crst_262_23","DOIUrl":"https://doi.org/10.4103/crst.crst_262_23","url":null,"abstract":"Head-and-neck cancers are the most common malignancies in India.[1,2] These cancers exert a significant health burden in India, resulting in myriad social, economic, and psychological implications. The study conducted by Michaelraj et al.[3] meticulously delves into these cancers’ demographic and epidemiological characteristics in western Tamil Nadu. The local perspective from regional data sheds light on the concentrated distribution of these cancers and underscores the influential role of local variation in risk factors. Such insights hold the potential to inform targeted interventions encompassing education, prevention, and early detection strategies for these cancers.[4] The oral cavity predominantly serves as the primary site for head-and-neck cancers among Indian patients.[5] The study by Michaelraj et al.[3] identified the tongue as the most common subsite within this cohort of patients—a trend in line with other research studies conducted in south India. However, buccal mucosa traditionally ranks as India’s most common subsite for oral cavity cancers. It is worth noting that incorporating questions regarding the prevalence and practices of tobacco chewing within the questionnaire could have unveiled valuable insights. Furthermore, an exploration into the gender-based variations in the distribution of head-and-neck cancer sites could have enriched the study. Divergent risk factors across genders might significantly contribute to this disparity.[6] Among the critical determinants of survival in these aggressive cancers, the disease stage plays a major role. Data on the disease stage at presentation could have helped to devise appropriate strategies for earlier detection.[7] Although the study encompasses a cohort of 150 patients from a single tertiary-care institute in western Tamil Nadu, more comprehensive insights could have been gained by including a larger sample size from diverse centers across Tamil Nadu. Furthermore, tracking changes in cancer trends over the past decade could have yielded valuable temporal insights. In light of these considerations, the article by Michaelraj et al.[3] strongly underscores the paramount importance of tobacco, alcohol, and smoking as the foremost risk factors for these cancers.[8] Emphasis on comprehensive community-based tobacco cessation programs[9,10] emerges as a clear imperative. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135784565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Cancer Research, Statistics, and Treatment
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1